OPKO Health Inc XCY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $1.32
- Day Range
- $1.35–1.35
- 52-Week Range
- $0.79–—
- Bid/Ask
- $1.34 / $1.40
- Market Cap
- $933.35 Mil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.44
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,930
- Website
- https://www.opko.com
Comparables
Valuation
|
Metric
|
XCY
|
688468
|
603658
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 21.05 | 21.83 |
Price/Book Value | 0.71 | 2.05 | 3.41 |
Price/Sales | 1.44 | 6.16 | 6.08 |
Price/Cash Flow | — | 14.42 | 15.34 |
Price/Earnings
XCY
688468
603658
Financial Strength
|
Metric
|
XCY
|
688468
|
603658
|
|---|---|---|---|
Quick Ratio | 0.71 | 4.71 | 0.99 |
Current Ratio | 1.63 | 5.48 | 2.71 |
Interest Coverage | −9.91 | 111.54 | 57.12 |
Quick Ratio
XCY
688468
603658
Profitability
|
Metric
|
XCY
|
688468
|
603658
|
|---|---|---|---|
Return on Assets (Normalized) | −10.22% | 7.46% | 11.37% |
Return on Equity (Normalized) | −14.83% | 9.59% | 15.28% |
Return on Invested Capital (Normalized) | −10.92% | 7.98% | 14.14% |
Return on Assets
XCY
688468
603658
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| Syxdbccgh | Mgj | $234.1 Bil | |||
| Danaher Corp
DHR
| Rpfnmgvy | Cxvwr | $197.8 Bil | |||
| IQVIA Holdings Inc
IQV
| Ktwjkyc | Gxvwd | $42.2 Bil | |||
| Agilent Technologies Inc
A
| Pbhcrjlkt | Cjwlk | $42.1 Bil | |||
| IDEXX Laboratories Inc
IDXX
| Tmmpsqggm | Tqk | $40.0 Bil | |||
| Mettler-Toledo International Inc
MTD
| Gpyqfklh | Zpcmm | $31.8 Bil | |||
| Icon PLC
ICLR
| Gspfkngl | Gxbxthw | $24.4 Bil | |||
| Illumina Inc
ILMN
| Dnmfgls | Jsvtgzy | $22.1 Bil | |||
| Waters Corp
WAT
| Frrqxttk | Llwjn | $21.1 Bil | |||
| Labcorp Holdings Inc
LH
| Xfklfmpcyb | Pkqhqsx | $18.4 Bil |
United States